In accordance with the provisions of the Regulations on the Administration of Narcotic Drugs and Psychotropic Substances and the Measures for the Scheduling of Non-Medicinal Narcotic Drugs and Psychotropic Substances, the Ministry of Public Security, the National Health Commission, and the National Medical Products Administration jointly issued an announcement on June 17, 2026, to include 16 substances, including difluoroetizolam, in the Catalogue of Non-Medicinal Narcotic Drugs and Psychotropic Substances, effective July 1, 2026.
Note: The scheduling of tiletamine (CAS: 14176-49-9) under this announcement excludes veterinary anesthetic preparations containing tiletamine that have been approved for marketing within the territory of China.
For further details, please refer to: https://www.mps.gov.cn/n6557558/c10498264/content.html
